Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Sort ascending Organization
Apr
12
2019
HIV/AIDS Drug Litigation Moves Forward Stark & Stark
Jun
24
2019
Historic Vote in Congress Aims to Protect State Cannabis Programs Steptoe & Johnson PLLC
Feb
12
2024
HIPAA and Part 2 Harmonized: What Health Care Organizations Need to Know Foley & Lardner LLP
Feb
14
2019
HIMMS19 Conference – Blockchain Symposium Recap Sheppard, Mullin, Richter & Hampton LLP
Jul
22
2016
Hillary Clinton’s Statements On GMOs Have Varied By Audience MapLight
Jul
13
2023
Highly Legal: Will Congress Legalize Mushrooms Before Marijuana? Bradley Arant Boult Cummings LLP
Mar
16
2013
Highlights of Michigan Public Service Commission Annual Report Varnum LLP
Mar
5
2024
Highlights from FDA Regulatory Developments in Clinical Trials: 2023 Recap and 2024 Forecast [Podcast] K&L Gates
Jan
9
2023
Highest French Administrative Court Lifts the Ban on CBD Flowers and Leaves Squire Patton Boggs (US) LLP
Sep
10
2015
Highest EU Court: REACH SVHC Thresholds Apply at Component – Not Product – Level Beveridge & Diamond PC
Jan
13
2023
Higher Prices in Pennsylvania and Liquor Law Reform in New Jersey Norris McLaughlin P.A.
Feb
23
2018
High Times in San Francisco: DA Promises To Expunge Cannabis Convictions Without Petitions Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Sep
19
2022
High Times Ahead for Employers in California Jackson Lewis P.C.
Aug
17
2017
High Time for Massachusetts Employers to Consider a Marijuana Use Policy Murtha Cullina
Jan
23
2023
High Stakes: What to do Now That Your New Jersey Cannabis Business Application Has Been Approved by the CRC Stark & Stark
Feb
23
2024
High Stakes: New Proposed Philadelphia Ordinance Regulating Skill-Based Games at Odds with State Police Cases Norris McLaughlin P.A.
May
23
2018
High Stakes for Marijuana Businesses: New Massachusetts Advertising & Marketing Regulations Wilson Elser Moskowitz Edelman & Dicker LLP
Jul
2
2020
High Risk of Second Requests in the Cannabis Industry Sheppard, Mullin, Richter & Hampton LLP
Oct
30
2023
High Protections on Information Relating to Employees’ Cannabis Use Sheppard, Mullin, Richter & Hampton LLP
Jun
1
2021
High Levels of Arsenic and Lead Found in Vinegar Products, Particularly Balsamics Keller and Heckman LLP
Feb
28
2013
High Impact Entrepreneurship in Wisconsin: The Smoke and the Fire Michael Best & Friedrich LLP
Aug
24
2018
High Hopes: Plaintiffs’ Lawyers Set Their Sights on Cannabis Industry in Two New TCPA Class Actions Womble Bond Dickinson (US) LLP
Aug
8
2013
High Growth Segment Businesses in the UK McDermott Will & Emery
Jan
24
2024
High Expectations: New Jersey’s Rocky Road to Cannabis Consumption Lounges Norris McLaughlin P.A.
Jun
20
2017
High Court Limits Litigation Forum Shopping Barnes & Thornburg LLP
Feb
4
2020
Hierarchy of Scientific Evidence Reigns Supreme: NJ Appellate Division Affirms Exclusion of Experts in Accutane Litigation Faegre Drinker
Jan
14
2016
HHS/USDA Release 2015-2020 Dietary Guidelines for Americans Morgan, Lewis & Bockius LLP
Apr
19
2024
HHS-OIG Highlights Anti-Fraud Safeguards for Patient Assistance Programs Backed Mainly By Drug Manufacturers Barnes & Thornburg LLP
Mar
7
2023
HHS-OIG Foregoes Sanctions On Drug Manufacturer For Providing Free Drugs To Patients Waiting For Insurance Authorization Barnes & Thornburg LLP
Feb
25
2023
HHS-OIG Declines to Impose Sanctions on Drug Manufacturer for Financial Assistance to Pediatric Patients with Rare Disease Barnes & Thornburg LLP
Nov
14
2023
HHS-HRSA Terminates 340B Drug Pricing Program Registration Waiver Barnes & Thornburg LLP
Jan
8
2024
HHS, ONC HTI-1 Final Rule Introduces New Transparency Requirements for Artificial Intelligence in Certified Health IT Mintz
Apr
27
2021
HHS to Repeal SUNSET Rule Keller and Heckman LLP
Jun
5
2020
HHS Rule is Good News for Prescription Drug Accumulator Programs Hunton Andrews Kurth
Oct
11
2021
HHS Rescinds Rule to Provide Insulin and Injectable Epinephrine at 340B Prices Nelson Mullins
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins